Literature DB >> 11087582

S-Acyl-2-thioethyl aryl phosphotriester derivatives as mononucleotide prodrugs.

N Schlienger1, S Peyrottes, T Kassem, J L Imbach, G Gosselin, A M Aubertin, C Périgaud.   

Abstract

The synthesis and biological activities of phosphotriester derivatives of 3'-azido-2',3'-dideoxythymidine (AZT) bearing a phenyl group or L-tyrosinyl residues are reported. The target compounds were obtained via either P(V) or P(III) chemistry from the appropriate aryl precursors. All the derivatives were evaluated for their in vitro anti-HIV activity, and they appeared to be potent inhibitors of HIV-1 replication in various cell culture experiments, with EC(50) values between the micro- and nanomolar range. Furthermore, compounds incorporating an amino- and/or acid-substituted tyrosinyl residue demonstrated significant anti-HIV effects in thymidine kinase-deficient (TK(-)) cells showing their ability to act as mononucleotide prodrugs. The proposed decomposition process of these mixed mononucleoside aryl phosphotriesters may involve esterase activation followed by phosphodiesterase hydrolysis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11087582     DOI: 10.1021/jm000996o

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

Review 1.  Synthesis of nucleoside phosphate and phosphonate prodrugs.

Authors:  Ugo Pradere; Ethel C Garnier-Amblard; Steven J Coats; Franck Amblard; Raymond F Schinazi
Journal:  Chem Rev       Date:  2014-08-21       Impact factor: 60.622

2.  Regulation of chemokine recognition by site-specific tyrosine sulfation of receptor peptides.

Authors:  Levi S Simpson; John Z Zhu; Theodore S Widlanski; Martin J Stone
Journal:  Chem Biol       Date:  2009-02-27

3.  Synthesis of 4-thiouridines with prodrug functionalization for RNA metabolic labeling.

Authors:  Sarah Moreno; Melanie Brunner; Isabel Delazer; Dietmar Rieder; Alexandra Lusser; Ronald Micura
Journal:  RSC Chem Biol       Date:  2022-02-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.